Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8822637 Somatostatin analogues

Patent 8822637 was granted and assigned to Novartis on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88226370

Patent Inventor Names

Bernhard Wietfeld0

David Bodmer0

Gisbert Weckbecker0

Heribert Hellstern0

Ian Lewis0

Ivo Felner0

Mark Meisenbach0

Rainer Albert0

...

Date of Patent

September 2, 2014

Patent Application Number

130489320

Date Filed

March 16, 2011

Patent Citations Received

‌

US Patent 11986529 Pharmaceutical compositions and related methods of delivery

‌

US Patent 11857595 Method of treating diseases

‌

US Patent 11890316 Oral octreotide therapy and contraceptive methods

‌

US Patent 11969471 Pharmaceutical compositions and related methods of delivery

Patent Primary Examiner

‌

David Lukton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8822637 Somatostatin analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API